152 related articles for article (PubMed ID: 18453785)
21. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis.
Gumina RJ; Foley DA; Tefferi A; Rooke TW; Shields RC
Angiology; 2002; 53(5):587-91. PubMed ID: 12365868
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
Kurihara A; Kobayashi I; Tamura K
Rinsho Ketsueki; 1989 Jan; 30(1):99-104. PubMed ID: 2716205
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of low-dose aspirin in polycythemia vera.
Landolfi R; Marchioli R; Kutti J; Gisslinger H; Tognoni G; Patrono C; Barbui T;
N Engl J Med; 2004 Jan; 350(2):114-24. PubMed ID: 14711910
[TBL] [Abstract][Full Text] [Related]
24. [Subacute intracoronary stent thrombosis in a patient with polycythaemia vera].
Hvelplund A; Hansen PR
Ugeskr Laeger; 2006 Nov; 168(47):4104-5. PubMed ID: 17134610
[TBL] [Abstract][Full Text] [Related]
25. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.
Elliott MA; Tefferi A
Br J Haematol; 2005 Feb; 128(3):275-90. PubMed ID: 15667529
[TBL] [Abstract][Full Text] [Related]
26. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
27. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
[No Abstract] [Full Text] [Related]
28. Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy.
Girodon F; Schaeffer C; Cleyrat C; Mounier M; Lafont I; Santos FD; Duval A; Maynadié M; Hermouet S
Haematologica; 2008 Nov; 93(11):1723-7. PubMed ID: 18728027
[TBL] [Abstract][Full Text] [Related]
29. Early medical treatment is life saving in acute Budd-Chiari due to polycythemia vera.
Karti SS; Yilmaz M; Kosucu P; Altun E; Kesen J; Arslan M; Ozgur O; Ovali E
Hepatogastroenterology; 2003; 50(50):512-4. PubMed ID: 12749260
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of specific thrombotic accidents in patients with thrombocytosis.
Randi ML; Fabris F; Tison T; Barbone E; Rossi C; Girolami A
Haematologia (Budap); 1993; 25(3):149-52. PubMed ID: 8119627
[TBL] [Abstract][Full Text] [Related]
31. Essential thrombocythemia--a cause of myocardial infarction in a young male.
Ghotekar LH; Dutta TK; Kumarasamy V
J Assoc Physicians India; 2001 Apr; 49():473-4. PubMed ID: 11762622
[No Abstract] [Full Text] [Related]
32. Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report.
Zhang Z; Wan X; Liu Y; Lin X; Ni Z; Yang X; Zhang L
Clin Appl Thromb Hemost; 2011 Oct; 17(5):532-4. PubMed ID: 20724303
[TBL] [Abstract][Full Text] [Related]
33. Thrombocythemia and myocardial ischemia with normal coronary angiogram.
Barr I; Cohen P; Berken A; Lown B
Arch Intern Med; 1974 Sep; 134(3):528-33. PubMed ID: 4212468
[No Abstract] [Full Text] [Related]
34. [Essential thrombocythemia in pregnancy. A case report and general considerations].
Dell'Isola A; Di Rosa G; Catalano D
Minerva Ginecol; 1997 Apr; 49(4):165-72. PubMed ID: 9206768
[TBL] [Abstract][Full Text] [Related]
35. 6-Thioguanine treatment of uncontrolled thrombocytosis in polycythemia vera and essential thrombocythemia.
Delfini C; Porcellini A; Izzi T; Baronciani D
Haematologica; 1984; 69(6):766-7. PubMed ID: 6441754
[No Abstract] [Full Text] [Related]
36. Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.
Thiele J; Kvasnicka HM; Diehl V
Acta Haematol; 2005; 113(4):213-9. PubMed ID: 15983426
[TBL] [Abstract][Full Text] [Related]
37. Low-dose aspirin in polycythemia vera.
Dutrillaux F; Maynadié M; Carli PM
N Engl J Med; 2004 Apr; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088322
[No Abstract] [Full Text] [Related]
38. [Essential thrombocytosis--a criteria diagnosis. Important to differentiate from reactive/secondary thrombocytosis].
Andreasson B; Johansson P; Samuelsson J
Lakartidningen; 2009 Jan 14-20; 106(3):110-3. PubMed ID: 19248460
[No Abstract] [Full Text] [Related]
39. Myocardial infarction and primary thrombocytosis in a young man.
Gabriel L; de Meester A
Acta Cardiol; 2003 Feb; 58(1):35-7. PubMed ID: 12625493
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
